Three independent discounted-cash-flow-style models value TransMedics Group, Inc. Common Stock every trading day. 0 of 3 currently price TMDX above its market price.
| Free Cash Flow model | $-2,600.43 |
| Excess Profit model | $-962.30 |
| Residual Earnings model | $-0.10 |
| Dividend Discount model | — |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +8.8% |
| Net debt / EBITDA | 4.7× |
| Gross margin | +59.9% |
| Revenue CAGR | +171.5% |
| Cash conversion | 1.0× |
| Dividend yield | — |
| Buyback yield | -4.5% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open TMDX in StockKitty